Horizant
NDC 53451-0103, gabapentin enacarbil, tablet, extended release, from Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals).
- Product NDC
- 53451-0103
- Status
- Listed
- Labeler
- Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022399
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/53451-0103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN ENACARBIL300 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 53451-0103-1 | 53451010301 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (53451-0103-1) |
| 53451-0103-9 | 53451010309 | 5 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (53451-0103-9) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/4c486fc7-c8c4-4c6c-b30c-366dabaeaaddNADAC price for package 53451010301
GET /v1/drugs/nadac/53451010301
Use it
Look up 53451-0103 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/53451-0103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 53451-0103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.